(Q53117568)
Statements
Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. (English)
Christian Morath
Changli Wei
Stephan Macher-Goeppinger
Vedat Schwenger
Martin Zeier
Jochen Reiser
1 March 2013
20
2
226-229